There are 2 papers on SSTR4 in aging research: none in people yet.
At a glance
6 trials, 5 with no results posted.
- 6 trials, 5 with no results posted
- 1 of 6 trials sponsored by developers of drugs aimed at it
- In silico2
Associations
5Cognitive function
upin silico1
1 study
Cognitive function
upin silico1
SSTR4 is associated with cognitive function in patients with schizophrenia.
“influence the pace of aging and cognitive functions (rs705935) through their quantitative trait loci effects on CpG sites within SSTR4.”
In silicoin patients with schizophrenia
PloS one
Biological age
upin silico1
1 study
Biological age
upin silico1
SSTR4 is associated with biological age in patients with schizophrenia.
“pinpointed several genetic variants (rs17691954, rs11464356, rs3109190, and rs145879288) that influence the pace of aging”
In silicoin patients with schizophrenia
PloS one
CG14631053 methylation
upin silico1
1 study
CG14631053 methylation
upin silico1
SSTR4 is associated with CG14631053 methylation in silico.
“Methylation levels of cg14631053 correlate with chronological age”
In silico
Methylation of SSTR4 promoter region in multiple mental health disorders
Frontiers in genetics
Schizophrenia
downin silico1
1 study
Schizophrenia
downin silico1
SSTR4 is associated with schizophrenia in silico.
“hypomethylation is associated with the onset of bipolar disorder and schizophrenia, rather than major depressive disorder”
In silico
Methylation of SSTR4 promoter region in multiple mental health disorders
Frontiers in genetics
Bipolar disorder
downin silico1
1 study
Bipolar disorder
downin silico1
SSTR4 is associated with bipolar disorder in silico.
“hypomethylation is associated with the onset of bipolar disorder and schizophrenia, rather than major depressive disorder”
In silico
Methylation of SSTR4 promoter region in multiple mental health disorders
Frontiers in genetics